Literature DB >> 9431404

Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.

C L Smith1, I Brown, B M Torraca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9431404     DOI： 10.1086/516993

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.

Authors:  Yat Yee Wong; Eva G Rakasz; David J Gasper; Thomas C Friedrich; Lauren A Trepanier
Journal:  Toxicology       Date:  2016-08-23       Impact factor: 4.221

2.  Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.

Authors:  Jen-Jia Yang; Chung-Hao Huang; Chun-Eng Liu; Hung-Jen Tang; Chia-Jui Yang; Yi-Chien Lee; Kuan-Yeh Lee; Mao-Song Tsai; Shu-Wen Lin; Yen-Hsu Chen; Po-Liang Lu; Chien-Ching Hung
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

3.  Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.

Authors:  Yat Yee Wong; Brian Johnson; Thomas C Friedrich; Lauren A Trepanier
Journal:  Pharmacol Res Perspect       Date:  2017-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.